CA2167706A1 - Modified dna virus vectors and uses therefor - Google Patents

Modified dna virus vectors and uses therefor

Info

Publication number: CA2167706A1
Authority: CA; Canada
Prior art keywords: virus; restriction enzyme; site; cassette; unique
Prior art date: 1993-07-27
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA 2167706

Other languages

English (en)

French (fr)

Inventor

Nigel Fraser

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Wistar Institute of Anatomy and Biology

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-07-27

Filing date

1994-07-22

Publication date

1995-02-09

1994-07-22 Application filed by Individual filed Critical Individual

1995-02-09 Publication of CA2167706A1 publication Critical patent/CA2167706A1/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2468—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on beta-galactose-glycoside bonds, e.g. carrageenases (3.2.1.83; 3.2.1.157); beta-agarase (3.2.1.81)
- C12N9/2471—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01023—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16641—Use of virus, viral particle or viral elements as a vector
- C12N2710/16643—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Wood Science & Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Zoology (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Biomedical Technology (AREA)
Microbiology (AREA)
Molecular Biology (AREA)
Medicinal Chemistry (AREA)
Virology (AREA)
Physics & Mathematics (AREA)
Biophysics (AREA)
Plant Pathology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

CA 2167706 1993-07-27 1994-07-22 Modified dna virus vectors and uses therefor Abandoned CA2167706A1 (en)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date
US9796593A	1993-07-27	1993-07-27
US08/097,965		1993-07-27
US26723194A	1994-06-29	1994-06-29
US08/267,231		1994-06-29

Publications (1)

Publication Number	Publication Date
CA2167706A1 true CA2167706A1 (en)	1995-02-09

Family

ID=26793823

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA 2167706 Abandoned CA2167706A1 (en)	1993-07-27	1994-07-22	Modified dna virus vectors and uses therefor

Country Status (4)

Country	Link
EP (1)	EP0722493A1 (ja)
JP (1)	JPH09501564A (ja)
CA (1)	CA2167706A1 (ja)
WO (1)	WO1995004139A1 (ja)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5763217A (en) *	1993-11-10	1998-06-09	University Of British Columbia	Method of using, process of preparing and composition comprising recombinant herpesvirus vectors
US6544523B1 (en)	1996-11-13	2003-04-08	Chiron Corporation	Mutant forms of Fas ligand and uses thereof
US5998174A (en) *	1997-05-12	1999-12-07	University Of Pittsburgh Of The Commonwealth System Of Higher Education	Multigene vectors
EP2386629A1 (en)	1997-10-14	2011-11-16	Darwin Molecular Corporation	Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities
BR9813930A (pt)	1997-11-06	2006-12-19	Chiron Spa	antìgeno neisserial
WO1999036544A2 (en)	1998-01-14	1999-07-22	Chiron S.P.A.	Neisseria meningitidis antigens
CN101293920B (zh)	1998-05-01	2012-07-18	诺华疫苗和诊断公司	脑膜炎奈瑟球菌抗原和组合物
JP2003518363A (ja)	1999-04-30	2003-06-10	カイロンエセ．ピー．アー．	保存されたナイセリア抗原
GB9911683D0 (en)	1999-05-19	1999-07-21	Chiron Spa	Antigenic peptides
GB9916529D0 (en)	1999-07-14	1999-09-15	Chiron Spa	Antigenic peptides
DK1801219T3 (en)	1999-10-29	2015-12-07	Glaxosmithkline Biolog Sa	Neisseriale antigenic peptides.
ES2588917T3 (es)	2000-01-17	2016-11-07	Glaxosmithkline Biologicals Sa	Vacuna de VME suplementada contra meningococo
EP1950297A2 (en)	2000-05-31	2008-07-30	Novartis Vaccines and Diagnostics, Inc.	Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers
AU2002214127B2 (en)	2000-10-27	2007-06-07	J. Craig Venter Institute, Inc.	Nucleic acids and proteins from streptococcus groups A and B
GB0107661D0 (en)	2001-03-27	2001-05-16	Chiron Spa	Staphylococcus aureus
GB0107658D0 (en)	2001-03-27	2001-05-16	Chiron Spa	Streptococcus pneumoniae
NZ546711A (en)	2001-12-12	2008-06-30	Chiron Srl	Immunisation against chlamydia trachomatis
ATE466875T1 (de)	2002-11-15	2010-05-15	Novartis Vaccines & Diagnostic	Unerwartete oberflächenproteine in neisseria meningitidis
GB0308198D0 (en)	2003-04-09	2003-05-14	Chiron Srl	ADP-ribosylating bacterial toxin
WO2005049846A2 (en)	2003-11-17	2005-06-02	Crusade Laboratories Limited	Mutant herpes simplex virus and use thereof in the treatment of squamous cell cancer
US7897146B2 (en)	2003-11-17	2011-03-01	Crusade Laboratories Limited	Treatment using herpes simplex virus
GB0326798D0 (en)	2003-11-17	2003-12-24	Crusade Lab Ltd	Methods for generating mutant virus
KR20120126130A (ko)	2004-03-29	2012-11-20	가르파마 컴퍼니 리미티드	신규 갈렉틴 9 개변체 단백질 및 그 용도
EP2054431B1 (en)	2006-06-09	2011-08-31	Novartis AG	Conformers of bacterial adhesins
EP4179085A1 (en) *	2020-07-07	2023-05-17	Oriengene Biotechnology Ltd	Guide rna for hsv-1 gene editing and method thereof

1994
- 1994-07-22 EP EP94925681A patent/EP0722493A1/en not_active Withdrawn
- 1994-07-22 JP JP7505891A patent/JPH09501564A/ja active Pending
- 1994-07-22 CA CA 2167706 patent/CA2167706A1/en not_active Abandoned
- 1994-07-22 WO PCT/US1994/008243 patent/WO1995004139A1/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
JPH09501564A (ja)	1997-02-18
EP0722493A1 (en)	1996-07-24
WO1995004139A1 (en)	1995-02-09

Publication	Publication Date	Title
CA2167706A1 (en)	1995-02-09	Modified dna virus vectors and uses therefor
US5837532A (en)	1998-11-17	Herpes simplex cirus type 1 mutant
US6719982B1 (en)	2004-04-13	Mutant herpes simplex viruses and uses thereof
Fraefel et al.	1996	Helper virus-free transfer of herpes simplex virus type 1 plasmid vectors into neural cells
US5849571A (en)	1998-12-15	Latency active herpes virus promoters and their use
US5763217A (en)	1998-06-09	Method of using, process of preparing and composition comprising recombinant herpesvirus vectors
Lachmann et al.	1997	Utilization of the herpes simplex virus type 1 latency-associated regulatory region to drive stable reporter gene expression in the nervous system
EP0176170B1 (en)	1992-08-19	Herpes simplex virus as a vector
US20020028925A1 (en)	2002-03-07	Hsv viral vector
Fisher et al.	1986	Isolation and characterisation of herpes simplex virus type 1 mutants which fail to induce dUTPase activity
Jones et al.	1990	Analysis of the transcriptional promoter which regulates the latency-related transcript of bovine herpesvirus 1
AU3700797A (en)	1998-02-20	Hsv strain lacking functional icp27 and icp34.5 genes
KR20220016150A (ko)	2022-02-08	재조합 헤르페스비랄레스 벡터
KR100507399B1 (ko)	2005-08-10	진핵생물의 유전자 발현 카세트 및 그의 용도
Rinaldi et al.	1999	A non-cytotoxic herpes simplex virus vector which expresses Cre recombinase directs efficient site specific recombination
WO1999060145A1 (en)	1999-11-25	Mutant herpes simplex viruses and uses thereof
JP2002526039A (ja)	2002-08-20	突然変異ヘルペスウイルスを増殖するための細胞系
Johnson et al.	1994	Replication-defective recombinant herpes simplex virus vectors
AU760308B2 (en)	2003-05-15	Latency-active regulatory sequences of herpesviruses and latency-inactive herpesviruses for gene transfer
Fuchs et al.	1994	A novel intergenic site for integration and expression of foreign genes in the genome of pseudorabies virus

Legal Events

Date	Code	Title	Description
1997-07-22	FZDE	Dead